{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T13:46:33Z","timestamp":1776260793649,"version":"3.50.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T00:00:00Z","timestamp":1636588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T00:00:00Z","timestamp":1636588800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiologe"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s00117-021-00935-y","type":"journal-article","created":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T16:03:10Z","timestamp":1636646590000},"page":"30-34","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Nutzen der Radioonkologie beim solit\u00e4ren Plasmozytom oder multiplen Myelom","Benefits of radiotherapy for patients with solitary plasmacytoma or multiple myeloma"],"prefix":"10.1007","volume":"62","author":[{"given":"Laila","family":"K\u00f6nig","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaus","family":"Herfarth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,11,11]]},"reference":[{"issue":"2","key":"935_CR1","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0360-3016(96)00334-3","volume":"36","author":"TW Bolek","year":"1996","unstructured":"Bolek\u00a0TW, Marcus\u00a0RB Jr., Mendenhall\u00a0NP (1996) Solitary plasmacytoma of bone and soft tissue. Int J Radiat Oncol Biol Phys 36(2):329\u2013333","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"935_CR2","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ijrobp.2005.06.039","volume":"64","author":"M Ozsahin","year":"2006","unstructured":"Ozsahin\u00a0M et\u00a0al (2006) Outcomes and patterns of failure in solitary plasmacytoma: a\u00a0multicenter Rare Cancer Network study of 258\u00a0patients. Int J Radiat Oncol Biol Phys 64(1):210\u2013217","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"935_CR3","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12885-016-3015-5","volume":"17","author":"N Thumallapally","year":"2017","unstructured":"Thumallapally\u00a0N et al (2017) Solitary plasmacytoma: population-based analysis of survival trends and effect of various treatment modalities in the USA. BMC Cancer 17(1):13","journal-title":"BMC Cancer"},{"issue":"6","key":"935_CR4","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1182\/blood.V96.6.2037","volume":"96","author":"MA Dimopoulos","year":"2000","unstructured":"Dimopoulos\u00a0MA et\u00a0al (2000) Solitary plasmacytoma of bone and asymptomatic multiple myeloma. Blood 96(6):2037\u20132044","journal-title":"Blood"},{"issue":"4","key":"935_CR5","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0167-8140(90)90003-F","volume":"17","author":"NA Mayr","year":"1990","unstructured":"Mayr\u00a0NA et\u00a0al (1990) The role of radiation therapy in the treatment of solitary plasmacytomas. Radiother Oncol 17(4):293\u2013303","journal-title":"Radiother Oncol"},{"issue":"4","key":"935_CR6","doi-asserted-by":"crossref","first-page":"e206","DOI":"10.1016\/S1470-2045(17)30189-4","volume":"18","author":"M Cavo","year":"2017","unstructured":"Cavo\u00a0M et al (2017) Role of (18)F-FDG PET\/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a\u00a0consensus statement by the International Myeloma Working Group. Lancet Oncol 18(4):e206\u2013e217","journal-title":"Lancet Oncol"},{"issue":"6","key":"935_CR7","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1053\/j.semnuclmed.2007.07.002","volume":"37","author":"E Even-Sapir","year":"2007","unstructured":"Even-Sapir\u00a0E et al (2007) 18F-Fluoride positron emission tomography and positron emission tomography\/computed tomography. Semin Nucl Med 37(6):462\u2013469","journal-title":"Semin Nucl Med"},{"issue":"5","key":"935_CR8","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1089\/108497803770418382","volume":"18","author":"H Schirrmeister","year":"2003","unstructured":"Schirrmeister\u00a0H et\u00a0al (2003) Positron emission tomography (PET) for staging of solitary plasmacytoma. Cancer Biother Radiopharm 18(5):841\u2013845","journal-title":"Cancer Biother Radiopharm"},{"key":"935_CR9","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/1471-2407-6-118","volume":"6","author":"D Knobel","year":"2006","unstructured":"Knobel\u00a0D et\u00a0al (2006) Prognostic factors in solitary plasmacytoma of the bone: a\u00a0multicenter Rare Cancer Network study. BMC Cancer 6:118","journal-title":"BMC Cancer"},{"issue":"11","key":"935_CR10","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/0360-3016(80)90006-1","volume":"6","author":"CM Mendenhall","year":"1980","unstructured":"Mendenhall\u00a0CM, Thar\u00a0TL, Million\u00a0RR (1980) Solitary plasmacytoma of bone and soft tissue. Int J Radiat Oncol Biol Phys 6(11):1497\u20131501","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"935_CR11","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.ijrobp.2018.05.009","volume":"101","author":"RW Tsang","year":"2018","unstructured":"Tsang\u00a0RW et\u00a0al (2018) Radiation therapy for solitary plasmacytoma and multiple myeloma: guidelines from the International Lymphoma Radiation Oncology. Int J Radiat Oncol Biol Phys 101(4):794\u2013808","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"935_CR12","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.ijrobp.2005.09.019","volume":"64","author":"L Tournier-Rangeard","year":"2006","unstructured":"Tournier-Rangeard\u00a0L et al (2006) Radiotherapy for solitary extramedullary plasmacytoma in the head-and-neck region: a dose greater than 45\u202fGy to the target volume improves the local control. Int J Radiat Oncol Biol Phys 64(4):1013\u20131017","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"12","key":"935_CR13","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.6004\/jnccn.2020.0057","volume":"18","author":"SK Kumar","year":"2020","unstructured":"Kumar\u00a0SK et\u00a0al (2020) Multiple myeloma, version 3.2021, NCCN clinical practice guidelines in oncology. J\u00a0Natl Compr Canc Netw 18(12):1685\u20131717","journal-title":"J Natl Compr Canc Netw"},{"issue":"6","key":"935_CR14","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/j.1365-2141.2004.04834.x","volume":"124","author":"R Soutar","year":"2004","unstructured":"Soutar\u00a0R et\u00a0al (2004) Guidelines on the diagnosis and management of solitary plasmacytoma of bone and solitary extramedullary plasmacytoma. Br J Haematol 124(6):717\u2013726","journal-title":"Br J Haematol"},{"key":"935_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/s00405-017-4817-z","author":"B Venkatesulu","year":"2017","unstructured":"Venkatesulu\u00a0B et\u00a0al (2017) Pattern of care and impact of prognostic factors on the outcome of head and neck extramedullary plasmacytoma: a\u00a0systematic review and individual patient data analysis of 315\u00a0cases. Eur Arch Otorhinolaryngol. https:\/\/doi.org\/10.1007\/s00405-017-4817-z","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"2","key":"935_CR16","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.ijrobp.2010.11.037","volume":"82","author":"R Sasaki","year":"2012","unstructured":"Sasaki\u00a0R et al (2012) Multi-institutional analysis of solitary extramedullary plasmacytoma of the head and neck treated with curative radiotherapy. Int J Radiat Oncol Biol Phys 82(2):626\u2013634","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"19","key":"935_CR17","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1056\/NEJMoa022340","volume":"348","author":"JA Child","year":"2003","unstructured":"Child\u00a0JA et al (2003) High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma. N\u00a0Engl J Med 348(19):1875\u20131883","journal-title":"N Engl J Med"},{"issue":"20","key":"935_CR18","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1182\/blood-2014-09-568915","volume":"125","author":"P Moreau","year":"2015","unstructured":"Moreau\u00a0P, Attal\u00a0M, Facon\u00a0T (2015) Frontline therapy of multiple myeloma. Blood 125(20):3076\u20133084","journal-title":"Blood"},{"issue":"suppl_4","key":"935_CR19","doi-asserted-by":"crossref","first-page":"iv52","DOI":"10.1093\/annonc\/mdx096","volume":"28","author":"P Moreau","year":"2017","unstructured":"Moreau\u00a0P et al (2017) Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 28(suppl_4):iv52","journal-title":"Ann Oncol"},{"issue":"3","key":"935_CR20","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1182\/blood.V99.3.731","volume":"99","author":"P Moreau","year":"2002","unstructured":"Moreau\u00a0P et\u00a0al (2002) Comparison of 200\u202fmg\/m(2) melphalan and 8\u202fGy total body irradiation plus 140\u202fmg\/m(2) melphalan as conditioning regimens for peripheral blood stem cell transplantation in patients with newly diagnosed multiple myeloma: final analysis of the Intergroupe Francophone du Myelome 9502 randomized trial. Blood 99(3):731\u2013735","journal-title":"Blood"},{"issue":"3","key":"935_CR21","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1046\/j.1365-2141.2001.03206.x","volume":"115","author":"UK myeloma forum. British Committee for Standards in Haematology","year":"2001","unstructured":"UK myeloma forum. British Committee for Standards in Haematology (2001) Diagnosis and management of multiple myeloma. Br J Haematol 115(3):522\u2013540. https:\/\/pubmed.ncbi.nlm.nih.gov\/11736932\/","journal-title":"Br J Haematol"},{"issue":"29","key":"935_CR22","doi-asserted-by":"crossref","first-page":"4521","DOI":"10.1200\/JCO.2010.29.7929","volume":"28","author":"H Lokhorst","year":"2010","unstructured":"Lokhorst\u00a0H et al (2010) International Myeloma Working Group consensus statement regarding the current status of allogeneic stem-cell transplantation for multiple myeloma. J\u00a0Clin Oncol 28(29):4521\u20134530","journal-title":"J Clin Oncol"},{"issue":"22","key":"935_CR23","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1200\/JCO.2010.32.7312","volume":"29","author":"B Bjorkstrand","year":"2011","unstructured":"Bjorkstrand\u00a0B et al (2011) Tandem autologous\/reduced-intensity conditioning allogeneic stem-cell transplantation versus autologous transplantation in myeloma: long-term follow-up. J\u00a0Clin Oncol 29(22):3016\u20133022","journal-title":"J Clin Oncol"},{"issue":"2","key":"935_CR24","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/cncr.20755","volume":"103","author":"C Featherstone","year":"2005","unstructured":"Featherstone\u00a0C et al (2005) Estimating the optimal utilization rates of radiotherapy for hematologic malignancies from a\u00a0review of the evidence: part II-leukemia and myeloma. Cancer 103(2):393\u2013401","journal-title":"Cancer"},{"issue":"10","key":"935_CR25","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.3324\/haematol.2014.117176","volume":"100","author":"E Terpos","year":"2015","unstructured":"Terpos\u00a0E et al (2015) European Myeloma Network guidelines for the management of multiple myeloma-related complications. Haematologica 100(10):1254\u20131266","journal-title":"Haematologica"},{"issue":"2","key":"935_CR26","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s00066-010-2155-9","volume":"187","author":"M Balducci","year":"2011","unstructured":"Balducci\u00a0M et al (2011) Impact of radiotherapy on pain relief and recalcification in plasma cell neoplasms: long-term experience. Strahlenther Onkol 187(2):114\u2013119","journal-title":"Strahlenther Onkol"},{"issue":"9","key":"935_CR27","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00066-008-1808-4","volume":"184","author":"T Stolting","year":"2008","unstructured":"Stolting\u00a0T et\u00a0al (2008) Total and single doses influence the effectiveness of radiotherapy in palliative treatment of plasmacytoma. Strahlenther Onkol 184(9):465\u2013472","journal-title":"Strahlenther Onkol"},{"issue":"9","key":"935_CR28","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1007\/s00066-017-1154-5","volume":"193","author":"M Rudzianskiene","year":"2017","unstructured":"Rudzianskiene\u00a0M et\u00a0al (2017) Single vs. multiple fraction regimens for palliative radiotherapy treatment of multiple myeloma: a prospective randomised study. Strahlenther Onkol 193(9):742\u2013749","journal-title":"Strahlenther Onkol"},{"issue":"5","key":"935_CR29","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/0360-3016(93)90308-I","volume":"25","author":"BR Leigh","year":"1993","unstructured":"Leigh\u00a0BR et\u00a0al (1993) Radiation therapy for the palliation of multiple myeloma. Int J Radiat Oncol Biol Phys 25(5):801\u2013804","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"11","key":"935_CR30","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1007\/PL00002317","volume":"176","author":"S Mose","year":"2000","unstructured":"Mose\u00a0S et\u00a0al (2000) Role of radiotherapy in the treatment of multiple myeloma. Strahlenther Onkol 176(11):506\u2013512","journal-title":"Strahlenther Onkol"},{"issue":"5","key":"935_CR31","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/j.ijrobp.2005.10.018","volume":"64","author":"D Rades","year":"2006","unstructured":"Rades\u00a0D et al (2006) Short-course radiotherapy is not optimal for spinal cord compression due to myeloma. Int J Radiat Oncol Biol Phys 64(5):1452\u20131457","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"7","key":"935_CR32","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s00761-009-1629-9","volume":"15","author":"D Rades","year":"2009","unstructured":"Rades\u00a0D (2009) Externe Strahlentherapie zur Schmerzkontrolle. Onkologe 15(7):669\u2013679","journal-title":"Onkologe"},{"issue":"4","key":"935_CR33","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1046\/j.1365-2141.1997.d01-2108.x","volume":"96","author":"F Lecouvet","year":"1997","unstructured":"Lecouvet\u00a0F et al (1997) Long-term effects of localized spinal radiation therapy on vertebral fractures and focal lesions appearance in patients with multiple myeloma. Br J Haematol 96(4):743\u2013745","journal-title":"Br J Haematol"},{"issue":"12","key":"935_CR34","doi-asserted-by":"crossref","first-page":"e99","DOI":"10.1016\/j.clml.2017.09.005","volume":"17","author":"K Lang","year":"2017","unstructured":"Lang\u00a0K et\u00a0al (2017) Stability of spinal bone lesions in patients with multiple myeloma after radiotherapy\u2014A retrospective analysis of 130 cases. Clin Lymphoma Myeloma Leuk 17(12):e99\u2013e107","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"10","key":"935_CR35","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s000660050062","volume":"175","author":"S Koswig","year":"1999","unstructured":"Koswig\u00a0S et\u00a0al (1999) Palliative radiotherapy of bone metastases. A retrospective analysis of 176\u00a0patients. Strahlenther Onkol 175(10):509\u2013514","journal-title":"Strahlenther Onkol"},{"issue":"5","key":"935_CR36","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/leu.2013.293","volume":"28","author":"H Ludwig","year":"2014","unstructured":"Ludwig\u00a0H et\u00a0al (2014) International Myeloma Working Group recommendations for global myeloma care. Leukemia 28(5):981\u2013992","journal-title":"Leukemia"},{"issue":"2","key":"935_CR37","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.ijrobp.2008.08.050","volume":"74","author":"GJ Kubicek","year":"2009","unstructured":"Kubicek\u00a0GJ et\u00a0al (2009) Phase I trial using proteasome inhibitor bortezomib and concurrent temozolomide and radiotherapy for central nervous system malignancies. Int J Radiat Oncol Biol Phys 74(2):433\u2013439","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"935_CR38","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3816\/CCC.2010.n.017","volume":"9","author":"BH O\u2019Neil","year":"2010","unstructured":"O\u2019Neil\u00a0BH et al (2010) A phase I study of bortezomib in combination with standard 5\u2011fluorouracil and external-beam radiation therapy for the treatment of locally advanced or metastatic rectal cancer. Clin Colorectal Cancer 9(2):119\u2013125","journal-title":"Clin Colorectal Cancer"},{"issue":"2","key":"935_CR39","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.ijrobp.2009.07.1715","volume":"78","author":"TJ Pugh","year":"2010","unstructured":"Pugh\u00a0TJ et\u00a0al (2010) Phase I trial of bortezomib and concurrent external beam radiation in patients with advanced solid malignancies. Int J Radiat Oncol Biol Phys 78(2):521\u2013526","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"935_CR40","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.clml.2014.07.010","volume":"14","author":"SM Shin","year":"2014","unstructured":"Shin\u00a0SM et\u00a0al (2014) Feasibility and efficacy of local radiotherapy with concurrent novel agents in patients with multiple myeloma. Clin Lymphoma Myeloma Leuk 14(6):480\u2013484","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"3","key":"935_CR41","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1179\/joc.2005.17.3.343","volume":"17","author":"MM Mohiuddin","year":"2005","unstructured":"Mohiuddin\u00a0MM, Harmon\u00a0DC, Delaney\u00a0TF (2005) Severe acute enteritis in a\u00a0multiple myeloma patient receiving bortezomib and spinal radiotherapy: case report. J\u00a0Chemother 17(3):343\u2013346","journal-title":"J Chemother"},{"issue":"2","key":"935_CR42","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.radonc.2007.12.015","volume":"86","author":"O Berges","year":"2008","unstructured":"Berges\u00a0O et\u00a0al (2008) Concurrent radiation therapy and bortezomib in myeloma patient. Radiother Oncol 86(2):290\u2013292","journal-title":"Radiother Oncol"},{"issue":"2","key":"935_CR43","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ijrobp.2006.05.031","volume":"66","author":"MS Anscher","year":"2006","unstructured":"Anscher\u00a0MS et al (2006) Assessing the ability of the antiangiogenic and anticytokine agent thalidomide to modulate radiation-induced lung injury. Int J Radiat Oncol Biol Phys 66(2):477\u2013482","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"935_CR44","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ijrobp.2008.03.046","volume":"73","author":"J Drappatz","year":"2009","unstructured":"Drappatz\u00a0J et\u00a0al (2009) A pilot safety study of lenalidomide and radiotherapy for patients with newly diagnosed glioblastoma multiforme. Int J Radiat Oncol Biol Phys 73(1):222\u2013227","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"935_CR45","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ijrobp.2007.09.016","volume":"71","author":"JP Knisely","year":"2008","unstructured":"Knisely\u00a0JP et\u00a0al (2008) A phase III study of conventional radiation therapy plus thalidomide versus conventional radiation therapy for multiple brain metastases (RTOG 0118). Int J Radiat Oncol Biol Phys 71(1):79\u201386","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Der Radiologe"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00117-021-00935-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00117-021-00935-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00117-021-00935-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,18]],"date-time":"2022-01-18T14:10:19Z","timestamp":1642515019000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00117-021-00935-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,11]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["935"],"URL":"https:\/\/doi.org\/10.1007\/s00117-021-00935-y","relation":{},"ISSN":["0033-832X","1432-2102"],"issn-type":[{"value":"0033-832X","type":"print"},{"value":"1432-2102","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,11]]},"assertion":[{"value":"20 October 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"L.\u00a0K\u00f6nig und K.\u00a0Herfarth geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}